Sanqi Games Invests $20 Million in BrainCo to Advance Non-Invasive BCI Commercialization

Investment Circle (ID: pedaily2012) October 29 News: Recently, 37 Interactive Entertainment (SZ002555) officially completed the investment in BrainCo.$20 millionInvestment. In the future, both parties will focus on scenario implementation and take social responsibility as the foundation to explore the commercialization path of brain-computer interface technology. While empowering enterprise business upgrades, they will promote the application of brain-computer interface technology in fields such as entertainment, culture, and XR. They will also explore its potential value in scenarios like education and healthcare, making brain-computer interface technology an important force in driving social progress.

BrainCo, founded in February 2015, is the first unicorn enterprise in China's brain-computer interface field and also the first Chinese team selected for Harvard University’s Innovation Lab. Currently, BrainCo's technical capabilities are among the global leaders in the brain-computer interface industry, with rare technological barriers and commercialization abilities in this domain. The company’s core team mostly comes from top institutions like Harvard and MIT, and it has been granted over 480 patents. Its core products have received international certifications such as FDA and CE, and are widely applied in areas including rehabilitation, consumer health, and human-computer interaction. Han Bicheng, the founder and CEO, has been appointed as an advisor in the "Innovation and Entrepreneurship" field by the Chief Executive of the Hong Kong Special Administrative Region, recognized as an industry leader across government, business, and academia.

Currently, BrainCo has built a product matrix around three major business sectors: "Human-Machine Interaction (HMI) + Medical and Consumer Electronics + Cutting-edge Solutions." It has also launched products such as the humanoid robot's dexterous hand for the embodied intelligence field, achieving the commercial implementation of brain-computer interface technology and validating the commercial application value of non-invasive brain-computer technology.